Equity

Is INCYTE CORP (INCY) undervalued?

$122.19+0.59% todayNasdaqGS · USD · last traded 2026-09-14 20:00 UTC

INCYTE CORP trades on a P/E of 19.06 against earnings growth of 61.6% a year over the last 3 years, giving a PEG ratio of 0.31 — below the 1.0 level conventionally read as inexpensive relative to growth.

Earnings figures are measured from INCY’s filed annual accounts, not estimated. PEG compares price to earnings growth alone — it says nothing about debt, cash generation, or what an acquirer would pay. Read it alongside the figures below rather than on its own.

PEG ratio0.31
01.02.03.0+
Convention reads below 1.0 as inexpensive relative to growth and above 2.0 as expensive, though typical ranges differ sharply by sector.
P/E ratio19.06
earnings growth (3-year CAGR)61.6%
PEG ratio0.31
Measured from INCY's filed annual accounts. Trailing, not forecast.
01

What it would cost to buy INCY

Enterprise value is what it would cost to take the whole company: every share at today’s price, plus the debt an acquirer assumes, less the cash they receive. For INCYTE CORP that is $40.73B.

Every term below is a line item from a filed statement. The numbers beside each one open the filing it came from — balance-sheet figures arrive already scaled, so there is no “in thousands” to catch you out.

199.8M shares · 10-Q cover page

market capitalisation$24.41B
total debt$19.78B
cash & equivalents$3.46B
enterprise value$40.73B
Cash as reported to 2026-03-31; debt to 2018-12-31 — the two are not from the same balance sheet.
Enterprise-value multiples for INCYTE CORP
MeasureValue
Diluted earnings per shareto 2025-12-31$6.41
P/E ratioto 2025-12-3119.1
Earnings growth (3-year CAGR)to 2025-12-3161.6%
PEG ratioto 2025-12-310.3
Market capitalisationto 2026-04-21$24.41B
Total debtto 2018-12-31$19.78B
Net debtto 2026-03-31$15.85B
Enterprise valueto 2026-03-31$40.73B
EBITDAto 2025-12-31$1.61B
Free cash flowto 2025-12-31$1.34B
EV / EBITDAto 2025-12-3125.3×
EV / Salesto 2025-12-317.9×
Free cash flow yieldto 2025-12-315.5%
Net debt / EBITDAto 2025-12-319.9×
Return on capital employedto 2025-12-316.0%

Earnings growth is measured across INCYTE CORP’s own filed annual accounts. PEG conventionally uses forecast growth from analyst estimates; filings contain only history, so this is trailing growth and will read differently from a PEG quoted elsewhere.

02

Against the sector

INCY against 4 listed companies sharing its classification — Services-Commercial Physical & Biological Research and related industries. A multiple means little on its own; the column that matters is the gap.

INCY compared with the median of 4 sector peers
MeasureINCYSector medianDifference
EV / EBITDA*25.3×16.1×+9.2×
EV / Sales*7.9×3.7×+4.2×
Net debt / EBITDA9.9×2.7×+7.2×
Return on capital employed6.0%20.1%14.1%
Operating margin29.5%14.6%+14.9%
Compared against

CRL, IQV, IT, PAYX.

Medians are taken across peers where the measure could be computed, so the sample differs by row. Green marks the direction conventionally read as cheaper or stronger — it is a direction, not a recommendation. * Price-based multiples move with the market; peer figures are a snapshot taken 2026-09-09. The remaining rows come from filed statements and hold until the next reporting season.

03

Market ratios

Price-based ratios from market data. Anything drawn from a filed statement is in the enterprise-value section above, with its source.

Valuation and financial-health metrics for INCYTE CORP (INCY)
MetricValue
Price$122.19
PEGY ratio
Dividend yield0.00%
Price / book
Price / sales
Return on equity2.0%
Profit margin
Operating margin
Debt / equity
Current ratio
Beta
52-week range$81.09 – $132.60

Not reported for INCY: pegy ratio, price / book, price / sales, profit margin, operating margin, debt / equity, current ratio, beta. A dash means the figure was not available from the source, not that it is zero.

04

Compare and chart

Compare INCY vs Competitors

Use the calculator below to see how INCY stacks up against other stocks in the same industry.

Enter a ticker to pull its filings and build the valuation from the statements.

Enter a ticker to begin

Quick picks:

05

About INCY’s valuation

What is the PEG ratio for INCYTE CORP (INCY)?
INCYTE CORP has a PEG ratio of 0.31, from a P/E of 19.06 and earnings growth of 61.6% a year measured across 3 years of filed accounts. That is below the 1.0 level conventionally read as inexpensive relative to growth. Note that PEG is conventionally quoted against forecast growth; this uses reported history, so it will differ from a PEG you see elsewhere.
Is INCY undervalued right now?
That depends on the measure. On PEG, INCY reads 0.31, below the 1.0 level conventionally read as inexpensive relative to growth. The PEG ratio compares price to earnings growth alone — it ignores debt, cash generation and asset backing, so it is a starting point rather than a conclusion. The enterprise-value measures above account for debt and cash; they often tell a different story.
What is the PEGY ratio for INCY?
The PEGY ratio for INCYTE CORP is —. PEGY adds the dividend yield of 0.00% to the growth rate in the denominator, which gives a fairer reading of companies returning cash as income rather than growth.
Where do these INCY figures come from?
Market price and capitalisation come from live market data; earnings, growth and dividend figures come from INCYTE CORP's published financial statements. Every derived ratio on this page shows the arithmetic that produced it.

This page describes published financial data. It is not investment advice and makes no recommendation to buy or sell INCY.